KalVista Pharmaceuticals (KALV)

[Value_Investor]

CBYL has Zero-Debt now which is a Sought-After Key fundamental for a Bio-Tech Nasdaq stock! The company has huge cash on the hand --- $36.88M which entiles $1.14 ~ $0.95 per share Huge Cash liquidation value v.s. the stock is trading at the ridiculous low price $0.4xxx currently! The BV/PPS ratio and CV/PPS ratio ever hit 3.18+ and 3.11+ respectively which are the Record high among all the Nasdaq Bio-Tech peers! Easy 200% quick huge gain from here in the coming weeks/months...

With almost the fundamental and financial balance sheet CBYL ever hit $1.43 just a few months ago! Both BV ($1.37) and CV ($1.40) are very close to that most recent high price ($1.43)!

Last Friday evening the bid was as high as $0.4802 but no any fill at all!